Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study

Authors:
  • IMIain B McInnes
    Iain B McInnes
  • PMPhilip J Mease
    Philip J Mease
  • AKAlan J Kivitz
    Alan J Kivitz
  • PRProton Rahman
    Proton Rahman
  • JRJürgen Rech
    Jürgen Rech
  • PCPhilip G Conaghan
    Philip G Conaghan
  • BKBruce Kirkham
    Bruce Kirkham
  • SNSandra Navarra
    Sandra Navarra
  • ABAshwini D Belsare
    Ashwini D Belsare
  • EDEumoprhia M Delicha
    Eumoprhia M Delicha
  • LPLuminita Pricop
    Luminita Pricop

Abstract
No abstract available
Funding Information
  • Novartis Pharma
  • National Institute for Health and Care Research

This publication has 30 references indexed in Scilit: